Illumina, Inc.

Illumina, Inc. stands as a global leader in providing innovative sequencing and array-based solutions essential for genetic and genomic analysis. The company's comprehensive product portfolio includes advanced instruments and a wide array of consumables, such as reagents, flow cells, and library preparation kits, which are critical for unlocking the power of the genome. Illumina offers solutions for various applications, from whole-genome sequencing of diverse organisms to highly targeted resequencing of specific genes, exomes, and RNA, enabling researchers and clinicians to delve into the intricacies of DNA and RNA. Beyond its hardware and consumables, Illumina provides crucial services including whole-genome sequencing, genotyping, and noninvasive prenatal testing, alongside robust product support. Its customer base is broad and influential, encompassing leading genomic research centers, esteemed academic institutions, government laboratories, and major hospitals. Furthermore, Illumina plays a vital role in the advancement of the pharmaceutical and biotechnology sectors, supports commercial molecular diagnostic laboratories, and contributes to the burgeoning field of consumer genomics. The company employs a direct sales force and partners with life-science distributors to ensure broad market access across the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa, solidifying its position as a cornerstone of modern genomic discovery and application.